Evidence map›Paper›PMID 23865750›Full record

ArticleJournal of medicinal chemistry2013

A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter.

Rosalba Perrone, Matteo Nadai, Ilaria Frasson, Jerrod A Poe, Elena Butovskaya, Thomas E Smithgall, Manlio Palumbo, Giorgio Palù, Sara N Richter

Abstract read
In one paragraph

Article in Journal of medicinal chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 190 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Rosalba PerroneDepartment of Molecular Medicine, University of Padua, Italy.
Matteo Nadai
Ilaria Frasson
Jerrod A Poe
Elena Butovskaya
Thomas E Smithgall
Manlio Palumbo
Giorgio Palù
Sara N Richter
University of Padua · ITUniversity of Pittsburgh · US

Funding

Small Molecule Inhibitors of HIV Nef SignalingR01AI057083 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SMITHGALL, THOMAS E. · 2003 to 2019
$5.1M
Structural Biology of HIV-1 Nef with Host Effectors and Small Molecule InhibitorsR01AI102724 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALVARADO, JOHN JEFF, SMITHGALL, THOMAS E. · 2013 to 2017
$1.9M
NIAID NIH HHS AI57083NIAID NIH HHS R01 AI057083NIAID NIH HHS R01 AI102724
6 · The paper itself

Abstract

G-Quadruplexes, noncanonical nucleic acid structures, act as silencers in the promoter regions of human genes; putative G-quadruplex forming sequences are also present in promoters of other mammals, yeasts, and prokaryotes. Here we show that also the HIV-1 LTR promoter exploits G-quadruplex-mediated transcriptional regulation with striking similarities to eukaryotic promoters and that treatment with a G-quadruplex ligand inhibits HIV-1 infectivity. Computational analysis on 953 HIV-1 strains substantiated a highly conserved G-rich sequence corresponding to Sp1 and NF-κB binding sites. Biophysical/biochemical analysis proved that two mutually exclusive parallel-like intramolecular G-quadruplexes, stabilized by small molecule ligands, primarily fold in this region. Mutations disrupting G-quadruplex formation enhanced HIV promoter activity in cells, whereas treatment with a G-quadruplex ligand impaired promoter activity and displayed antiviral effects. These findings disclose the possibility of inhibiting the HIV-1 LTR promoter by G-quadruplex-interacting small molecules, providing a new pathway to development of anti-HIV-1 drugs with unprecedented mechanism of action.

Indexed as

G-QuadruplexesPromoter Regions, GeneticHEK293 CellsHIV-1HIV Long Terminal RepeatHumans

Identifiers

PMID23865750
PMCPMC3791109
OpenAlexW1985970608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.